[Congressional Record Volume 170, Number 115 (Thursday, July 11, 2024)]
[Senate]
[Pages S4926-S4927]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2585. Mr. YOUNG (for himself and Mr. Padilla) submitted an 
amendment intended to be proposed by him to the bill S. 4638, to 
authorize appropriations for fiscal year 2025 for military activities 
of the Department of Defense, for military construction, and for 
defense activities of the Department of Energy, to prescribe military 
personnel strengths for such fiscal year, and for other purposes; which 
was ordered to lie on the table; as follows:

       At the end of subtitle E of title XII, add the following:

     SEC. 1272. REPORT ON INTERNATIONAL COLLABORATION ON DEFENSE 
                   BIOTECHNOLOGY RESEARCH AND DEVELOPMENT.

       (a) Report Required.--Not later than 180 days after the 
     date of the enactment of this Act, the Secretary of Defense, 
     in coordination with the Secretary of State and the Secretary 
     of Commerce, shall submit to the appropriate congressional 
     committees a report detailing any ongoing work with 
     international partners and treaty allies to advance research 
     and development on biotechnology, especially for applications 
     relevant to national defense.
       (b) Elements.--The report required by subsection (a) shall 
     include the following:
       (1) A description of the international security 
     partnerships that, as of the date on which the report is 
     submitted, do, or could, include biotechnology research and 
     development for defense, including--
       (A) the Five Eyes intelligence alliance;
       (B) the North Atlantic Treaty Organization (NATO); or
       (C) any defense cooperation agreement entered into--
       (i) with a major non-NATO ally designated under section 517 
     of the Foreign Assistance Act of 1961 (22 U.S.C. 2321k); or
       (ii) under section 2350a of title 10, United States Code, 
     or the Foreign Relations Authorization Act, Fiscal Year 2003 
     (Public Law 107-228).
       (2) A description of any challenges to collaborative 
     biotechnology research and development, including any 
     challenges that may prevent the partnerships described in 
     paragraph (1) from being leveraged to the fullest extent 
     possible.
       (3) A description of any limitations on co-investments 
     within those partnerships.
       (4) An assessment of whether any United States export 
     controls or other technology protections, including the 
     International

[[Page S4927]]

     Traffic in Arms Regulations, are hindering information 
     sharing and cooperation on defense biotechnology research and 
     development.
       (c) Form.--The report required by subsection (a) shall be 
     submitted in unclassified form, but may include a classified 
     annex.
       (d) Appropriate Congressional Committees Defined.--In this 
     section, the term ``appropriate congressional committees'' 
     means--
       (1) the Committee on Armed Services, the Committee on 
     Foreign Relations, and the Committee on Banking, Housing, and 
     Urban Affairs of the Senate; and
       (2) the Committee on Armed Services and the Committee on 
     Foreign Affairs of the House of Representatives.
                                 ______